文献速递消化、代谢与肾脏急症心脑血管急症重症综合管理与镇静镇痛

急诊科患者血清高钾血症与短期临床结局:一项多中心倾向匹配研究

Serum hyperkalemia and short-term clinical outcomes in emergency department patients: A multicenter propensity-matched study.
PubMed 文献 · Am J Emerg Med · 2026-09-16
一句话结论急诊非透析患者初始血钾越高,48小时内恶性心律失常、死亡、ICU入住和机械通气风险越高,临界高钾(5.01-5.49 mmol/L)总体风险也升高。

该多中心回顾性队列研究利用TriNetX网络纳入2010-2024年美国急诊成人(≥18岁)非透析患者,按初始血钾分层并与倾向匹配的正常血钾(3.5-5.0 mmol/L)对照比较。四个预设高钾层(5.5-5.99、6.0-6.49、6.5-6.99、≥7.0 mmol/L)共141,938例,匹配后保留140,288例,主要复合终点(48小时内心脏骤停、室速或室颤)风险从5.5-5.99 mmol/L的3.05%升至≥7.0 mmol/L的6.68%,对照组仅0.77-0.90%(RR 3.97-8.08);死亡率从2.04%升至5.79%,ICU入住和机械通气风险亦升高。探索性临界高钾组(5.01-5.49 mmol/L)匹配后主要终点1.52% vs 0.85%(RR 1.79, 95%CI 1.75-1.83),但孤立性室速/室颤未见增加。结论支持血钾作为风险分层标志物,但未确立钾特异性因果或剂量反应关系。

要点

  • 急诊非透析成人初始血钾5.5-5.99 mmol/L时48小时主要复合终点(心脏骤停/室速/室颤)风险3.05%,≥7.0 mmol/L时升至6.68%,匹配正常血钾对照仅0.77-0.90%。
  • 各高钾层与匹配对照相比主要终点RR为3.97-8.08,死亡率从5.5-5.99 mmol/L的2.04%升至≥7.0 mmol/L的5.79%,ICU入住和机械通气风险亦升高。
  • 临界高钾5.01-5.49 mmol/L组主要终点1.52% vs 对照0.85%(RR 1.79, 95%CI 1.75-1.83),但孤立性室速和室颤未见增加。
  • 研究为回顾性队列,倾向模型纳入人口学、合并症、实验室值和就诊生命体征,结果支持血钾用于风险分层,但不建立因果或剂量反应效应。

适用人群与场景

  • 美国急诊就诊的成人(≥18岁)非透析患者,数据来自TriNetX研究网络,就诊时间2010-2024年。
  • 按初始血清钾分层:临界高钾组5.01-5.49 mmol/L,预设高钾层5.5-5.99、6.0-6.49、6.5-6.99、≥7.0 mmol/L,各自与倾向匹配的正常血钾(3.5-5.0 mmol/L)对照比较。

诊断标准与关键阈值

  • 高钾分层界值:5.01-5.49 mmol/L为临界高钾;预设高钾层为5.5-5.99、6.0-6.49、6.5-6.99、≥7.0 mmol/L;正常血钾对照为3.5-5.0 mmol/L。
  • 主要复合终点为48小时内发生心脏骤停、室性心动过速或心室颤动;次要终点包括ICU入住、机械通气、低血糖和48小时内死亡。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 初始血钾≥5.5 mmol/L(尤其≥7.0 mmol/L)的急诊非透析成人,48小时内恶性心律失常、死亡、ICU入住和机械通气风险显著升高,需警惕并加强监测。
  • 临界高钾5.01-5.49 mmol/L总体临床风险亦升高(主要终点RR 1.79),但孤立性室速/室颤未增加。

研究设计与关键结果

  • 多中心回顾性队列研究,利用TriNetX网络纳入2010-2024年美国急诊成人(≥18岁)非透析患者;四个预设高钾层共141,938例,倾向匹配后保留140,288例。
  • 主要复合终点(48小时内心脏骤停、室速或室颤)风险从血钾5.5-5.99 mmol/L的3.05%升至≥7.0 mmol/L的6.68%,匹配正常血钾对照为0.77-0.90%(RR 3.97-8.08)。
  • 死亡率从血钾5.5-5.99 mmol/L的2.04%升至≥7.0 mmol/L的5.79%,ICU入住和机械通气风险亦相应升高。
  • 探索性临界高钾组(5.01-5.49 mmol/L)1,249,213例匹配等量对照,主要终点1.52% vs 0.85%(RR 1.79, 95%CI 1.75-1.83),孤立性室速和室颤未增加。

证据类型、等级与局限

  • 证据类型:多中心回顾性队列研究(TriNetX研究网络),非随机对照试验。
  • 原文未给出证据等级或推荐强度;倾向评分匹配用于控制人口学、合并症、实验室值和就诊生命体征等混杂因素。
  • 局限:回顾性设计;结论支持血钾作为风险分层标志物,但未确立钾特异性因果或剂量反应效应。

对床旁实践的改变

  • 急诊非透析成人初始血钾≥5.5 mmol/L可作为48小时恶性心律失常和死亡的风险分层标志,尤其≥7.0 mmol/L风险最高,应加强监测和评估ICU需求。
  • 临界高钾5.01-5.49 mmol/L总体临床风险升高(主要终点RR 1.79),但孤立性室速/室颤未增加,提示需关注整体病情而非仅心律失常风险。
  • 研究为回顾性关联分析,不能据此推断降低血钾可改善结局,临床处置仍应依据具体病情和现有指南。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: Hyperkalemia is a common and potentially life-threatening electrolyte disturbance encountered in the emergency department (ED), but the graded association between serum potassium and short-term clinical outcomes in non-dialysis patients remains uncertain.

METHODS: We conducted a multicenter retrospective cohort study using the TriNetX Research Network to examine short-term outcomes among adults (≥18 years) presenting to U.S. EDs between 2010 and 2024. Patients were categorized by initial serum potassium concentration, including a borderline-elevation group (5.01-5.49 mmol/L) and prespecified hyperkalemia strata of 5.5-5.99, 6.0-6.49, 6.5-6.99, and ≥ 7.0 mmol/L, with each group independently compared with propensity score-matched normokalemic controls (3.5-5.0 mmol/L). Propensity models included demographics, comorbidities, laboratory values, and presenting vital signs. The primary outcome was a composite of cardiac arrest, ventricular tachycardia, or ventricular fibrillation within 48 h. Secondary outcomes included ICU admission, mechanical ventilation, hypoglycemia, and death within 48 h.

RESULTS: Among 141,938 eligible patients in the four prespecified hyperkalemia strata, 140,288 were retained after matching. Primary-outcome risk increased from 3.05% at potassium 5.5-5.99 mmol/L to 6.68% at ≥7.0 mmol/L, compared with 0.77-0.90% among matched controls (RR 3.97-8.08). Mortality increased from 2.04% to 5.79%, with similarly higher risks of ICU admission and mechanical ventilation. In the exploratory borderline group, 1,249,213 patients were matched to an equal number of controls; the primary outcome occurred in 1.52% versus 0.85% (RR 1.79, 95% CI 1.75-1.83), although isolated ventricular tachycardia and ventricular fibrillation were not increased.

CONCLUSION: Higher initial serum potassium concentrations were associated with greater short-term clinical risk in ED patients. Borderline potassium elevation was also associated with increased overall clinical risk, although not with higher isolated ventricular arrhythmia rates. These findings support serum potassium as a risk-stratification marker but do not establish a potassium-specific causal or dose-response effect.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. O'Brien J, Patel MJ, Schrock JW, et al. Serum hyperkalemia and short-term clinical outcomes in emergency department patients: A multicenter propensity-matched study. Am J Emerg Med. 2026. PMID: 42777312. doi:10.1016/j.ajem.2026.09.028

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。